Therapy

Team 1 – Genomics and Pathophysiology of Myocardial Diseases

par

Team headed by Philippe Charron Team 1 focuses its research program on 4 research axes : To identify key-players (rare and frequent genetic variants, signaling pathways) in cardiomyopathies and channelopathies through genomics and omics approaches. To understand function, interactions and pathophysiology of key-players in these diseases through human cardiomyocytes (derived from iPS patients) and murine … Lire la suite

Team 2 – Atherothrombosis and Applied Pharmacology

par

Team headed by J.P. Collet The main goal of team 2 is to improve knowledge in cardiovascular medicine, from treatment strategies to education for primary prevention mainly in the field of atherothrombosis. Expanding of the group led to new areas of investigation including now cardiovascular epidemiology, education but also new technologies. Our cardiovascular research is … Lire la suite